News

Filter

Current filters:

SandozMarkets & Marketing

1 to 9 of 96887 results

EMA revises policy on conflict of interests

20-11-2014

The European Medicines Agency has today published its revised policy on handling declarations of interests…

EuropeFinancialPharmaceuticalRegulation

UK government looks to speed up access to new medicines

UK government looks to speed up access to new medicines

20-11-2014

The UK government has announced a substantial investment package from industry, and that it is to carry…

BiotechnologyPoliticsRegulationUKUnited Kingdom

Australia and New Zealand abandon plans to form joint regulator

Australia and New Zealand abandon plans to form joint regulator

20-11-2014

The Ministers for Health from Australia and New Zealand have confirmed they are to end efforts to establish…

Asia-PacificAustraliaNew ZealandRegulationTherapeutic Goods Administration

Generic versions of Valcyte and Activella hit the US market

20-11-2014

Ireland-domiciled pain drugmaker Endo International says that its Qualitest subsidiary has launched a…

ActivellaAmneal PharmaceuticalsEndo InternationalGenericsLopreezaMarkets & MarketingNovo NordiskOphthalmicsRocheUSAValcyteWomen's Health

ALK Abello files for European approval for its dust mite allergy sublingual tablets

ALK Abello files for European approval for its dust mite allergy sublingual tablets

20-11-2014

Denmark-based allergy specialist ALK Abello has filed a registration application for its house dust mite…

ALK AbelloDenmarkImmunologicalsPharmaceuticalRegulation

Mallinckrodt 4th-qtr sales and earnings beat analysts’ expectations

20-11-2014

US drugmaker Mallinckrodt has reported a strong set of financial results for the fourth-quarter and full…

FinancialMallinckrodtPharmaceutical

European prescribing trends for mCR prostate cancer

20-11-2014

Johnson & Johnson/AstraZeneca’s Zytiga (abiraterone acetate) is the clear agent of choice for second-line…

Astellas PharmaAstraZenecaBayerDendreonFranceGermanyItalyJohnson & JohnsonMarkets & MarketingMedivationOncologyPharmaceuticalProvengeSpainUKXofigoXtandiZytiga

3SBio gains exclusive license for PharmAbcine’s tanibirumab

20-11-2014

Chinese biotech firm 3SBio Inc has entered into an exclusive license with PharmAbcine for the development,…

3SBioBiotechnologyBrazilChinaLicensingOncologyPharmAbcineRussiatanibirumabThailand

1 to 9 of 96887 results

Back to top